S.L. 528.8 чл. 6

(1) Urgent Cases shall be assessed by the Chairperson in consultation with at least one of the clinicians sitting on the Committee as well as one pharmacist sitting on the Committee. The Directorate for Pharmaceutical Affairs shall determine which treatment is deemed to be urgent thus requiring an urgent decision.

(2) The Committee may adopt and publish any necessary procedure to process urgent and critical submissions.